7.75 USD
-0.28 (-3.49%)
7.75 USD
0 (0%)
Taking everything into account, BVS scores 5 out of 10 in our fundamental rating. BVS was compared to 185 industry peers in the Health Care Equipment & Supplies industry. BVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
In the past year BVS had a positive cash flow from operations.
In multiple years BVS reported negative net income over the last 5 years.
BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BVS has a better Return On Assets (1.11%) than 75.14% of its industry peers.
BVS's Return On Equity of 4.71% is fine compared to the rest of the industry. BVS outperforms 76.76% of its industry peers.
BVS has a better Return On Invested Capital (6.62%) than 80.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a Profit Margin of 1.39%. This is in the better half of the industry: BVS outperforms 74.05% of its industry peers.
BVS's Operating Margin of 8.03% is fine compared to the rest of the industry. BVS outperforms 75.68% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
BVS's Gross Margin of 67.76% is fine compared to the rest of the industry. BVS outperforms 72.97% of its industry peers.
In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BVS has been increased compared to 1 year ago.
BVS has more shares outstanding than it did 5 years ago.
BVS has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.27, we must say that BVS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BVS (1.27) is comparable to the rest of the industry.
The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BVS (6.22) is better than 76.76% of its industry peers.
BVS has a Debt/Equity ratio of 1.93. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.93, BVS is doing worse than 81.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.27 |
ROIC/WACC0.61
WACC10.94%
2.3 Liquidity
A Current Ratio of 1.74 indicates that BVS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.74, BVS is doing worse than 67.57% of the companies in the same industry.
BVS has a Quick Ratio of 1.14. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
BVS has a worse Quick ratio (1.14) than 70.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
Looking at the last year, BVS shows a small growth in Revenue. The Revenue has grown by 1.58% in the last year.
BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
Based on estimates for the next years, BVS will show a very strong growth in Earnings Per Share. The EPS will grow by 25.05% on average per year.
Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.58% on average per year.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
BVS is valuated correctly with a Price/Earnings ratio of 13.14.
Based on the Price/Earnings ratio, BVS is valued cheaper than 91.89% of the companies in the same industry.
BVS is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.65, which indicates a very decent valuation of BVS.
Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 95.14% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.98. BVS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.14 | ||
| Fwd PE | 9.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 90.81% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BVS is valued cheaper than 96.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12 | ||
| EV/EBITDA | 10.27 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BVS's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%
5. Dividend
5.1 Amount
No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
7.75
-0.28 (-3.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners74.45%
Inst Owner Change0.02%
Ins Owners2.5%
Ins Owner Change-0.35%
Market Cap641.39M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (97.42%)
Short Float %3.01%
Short Ratio5.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)0%
PT rev (3m)2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)0%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.14 | ||
| Fwd PE | 9.65 | ||
| P/S | 1.14 | ||
| P/FCF | 12 | ||
| P/OCF | 11.45 | ||
| P/B | 3.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.27 |
EPS(TTM)0.59
EY7.61%
EPS(NY)0.8
Fwd EY10.36%
FCF(TTM)0.65
FCFY8.34%
OCF(TTM)0.68
OCFY8.74%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.31
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.27 |
F-Score8
WACC10.94%
ROIC/WACC0.61
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.72%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status for BVS stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 13.14 and the Price/Book (PB) ratio is 3.86.
What is the financial health of BIOVENTUS INC - A (BVS) stock?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.